World's Best Scientists 2026 revealed!
VIEW LIST
Andrea Ardizzoni

Andrea Ardizzoni

University of Bologna
Italy

D-Index & Metrics

Medicine

D-Index
78
Citations
23450
World Ranking
18003
National Ranking
728

Andrea Ardizzoni publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Andrea Ardizzoni sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 769 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Andrea Ardizzoni D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Andrea Ardizzoni sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Andrea Ardizzoni is affiliated with the University of Bologna in Italy and focuses primarily on research within the field of Medicine, with a particular emphasis on Oncology. Their work extensively covers subfields such as Pulmonary and Respiratory Medicine, Epidemiology, Molecular Biology, and Surgery.

The scientist has contributed significantly to several main research topics, including:

  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Research Studies
  • Colorectal Cancer Treatments and Studies
  • Lung Cancer Diagnosis and Treatment
  • Peptidase Inhibition and Analysis
  • Neuroendocrine Tumor Research Advances

Their publication record shows multiple papers in prominent journals. Among the most recent notable papers are:

  • "Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up", 2021, Annals of Oncology
  • "First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC", 2023, New England Journal of Medicine
  • "Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial", 2020, ESMO Open
  • "ECOG performance status ≥2 as a prognostic factor in patients with advanced non small cell lung cancer treated with immune checkpoint inhibitors-A systematic review and meta-analysis of real world data", 2020, Lung Cancer
  • "CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations", 2020, European Journal of Cancer

The frequent co-authors associated with Andrea Ardizzoni include:

  • Francesco Gelsomino
  • Alessandro Di Federico
  • Andrea De Giglio
  • Francesca Sperandi
  • Filippo Gustavo Dall'Olio

The majority of their work has been published in key academic venues such as:

  • Annals of Oncology
  • Journal of Thoracic Oncology
  • Cancers
  • Journal of Clinical Oncology
  • European Journal of Cancer

Overall, Andrea Ardizzoni's research contributions focus on advancing understanding and treatment methodologies in oncology, with a strong concentration on lung and colorectal cancer studies, immunotherapy, and clinical outcomes related to cancer treatments.

Best Publications

  • Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer

    Antonino Musolino;Nadia Naldi;Beatrice Bortesi;Debora Pezzuolo

  • JC‐1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess ΔΨ changes in intact cells: implications for studies on mitochondrial functionality during apoptosis

    Stefano Salvioli;Andrea Ardizzoni;Claudio Franceschi;Andrea Cossarizza

  • Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non–Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis

    Andrea Ardizzoni;Luca Boni;Marcello Tiseo;Frank V. Fossella

  • Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.

    Andrea Ardizzoni;Heine Hansen;Per Dombernowsky;Teresa Gamucci

  • Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.

    Kazuhiko Nakagawa;Edward B Garon;Takashi Seto;Makoto Nishio

  • Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

    Jean Charles Soria;Enriqueta Felip;Manuel Cobo;Shun Lu

  • Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer

    U Gatzemeier;G Groth;C Butts;N Van Zandwijk

  • Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

    R. Rosell;U. Gatzemeier;D. C. Betticher;U. Keppler

  • Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer.

    John R. Eckardt;Joachim von Pawel;Jean-Louis Pujol;Zsolt Papai

  • Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    A.-M.C. Dingemans;M. Früh;A. Ardizzoni;B. Besse

  • Treatment of Advanced Non–Small-Cell Lung Cancer in the Elderly: Results of an International Expert Panel

    Cesare Gridelli;Matti Aapro;Andrea Ardizzoni;Lodovico Balducci

  • Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.

    G. Giaccone;A. Ardizzoni;A. Kirkpatrick;M. Clerico

  • Grading the neuroendocrine tumors of the lung: an evidence-based proposal

    G Rindi;C Klersy;F Inzani;G Fellegara

  • Low PD-1 Expression in Cytotoxic CD8+ Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value.

    Giulia Mazzaschi;Denise Madeddu;Angela Falco;Giovanni Bocchialini

  • Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: Results of an European Experts Panel

    C. Gridelli;A. Ardizzoni;T. Le Chevalier;C. Manegold

  • ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 Mg or 600 Mg, Taken With a Low-Fat Meal Versus 750 Mg in Fasted State in Patients With Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non-Small Cell Lung Cancer (NSCLC)

    Byoung Chul Cho;Dong Wan Kim;Alessandra Bearz;Scott A. Laurie

  • Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma

    C Bozzetti;F V Negri;C A Lagrasta;P Crafa

  • Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

    Lucia Del Mastro;Sabino De Placido;Paolo Bruzzi;Michele De Laurentiis

  • Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study.

    Antonino Musolino;Laura Ciccolallo;Michele Panebianco;Elisa Fontana

  • Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

    Jean-Charles Soria;Soria Jean-Charles;Enriqueta Felip;Felip Enriqueta

Frequent Co-Authors

Pierfranco Conte
Pierfranco Conte University of Padua
Enriqueta Felip
Enriqueta Felip Vall d'Hebron Institut de Recerca
Filippo De Marinis
Filippo De Marinis European Institute of Oncology
Luis Paz-Ares
Luis Paz-Ares Complutense University of Madrid
Pieter E. Postmus
Pieter E. Postmus Leiden University Medical Center
Paolo Bruzzi
Paolo Bruzzi Ospedale San Martino
Byoung Chul Cho
Byoung Chul Cho Yonsei University
Guido Rindi
Guido Rindi Catholic University of the Sacred Heart
Shirish M. Gadgeel
Shirish M. Gadgeel University of Michigan–Ann Arbor
Federico Cappuzzo
Federico Cappuzzo Azienda Unità Sanitaria Locale Della Romagna

External Links

Personal website of Andrea Ardizzoni

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in Medicine opens up diverse educational and career options beyond the traditional MD route. Many students start their healthcare careers with lpn online programs, which offer flexible, accessible training for those seeking to enter the field quickly. These programs can serve as stepping stones to advanced nursing roles or further medical study.

For those interested in mental health, pursuing the shortest pmhnp program online can lead to a career as a Psychiatric Mental Health Nurse Practitioner. This path allows students to complete their education faster and begin addressing critical mental health needs in their communities sooner.

Alternatively, if you’re drawn to the management side of healthcare, consider health administration degrees online. These programs blend healthcare knowledge with business and leadership skills, preparing graduates for important non-clinical roles in hospitals and healthcare organizations.

Those looking to advance further may pursue a master’s degree. The masters in healthcare administration cost can vary widely, but affordable online options make this advanced credential more accessible than ever. With the right program, you can build a rewarding career while managing tuition costs responsibly.

Best Scientists Citing Andrea Ardizzoni

Silvia Novello

Silvia Novello

University of Turin

Publications: 50

Benjamin Besse

Benjamin Besse

University of Paris-Saclay

Publications: 44

Martin Reck

Martin Reck

LungenClinic Grosshansdorf

Publications: 44

Enriqueta Felip

Enriqueta Felip

Vall d'Hebron Institut de Recerca

Publications: 39

Mauro Papotti

Mauro Papotti

University of Turin

Publications: 38

Giorgio V. Scagliotti

Giorgio V. Scagliotti

University of Turin

Publications: 37

Federico Cappuzzo

Federico Cappuzzo

Azienda Unità Sanitaria Locale Della Romagna

Publications: 36

David R. Gandara

David R. Gandara

University of California, Davis

Publications: 35

Mary O'Brien

Mary O'Brien

Royal Marsden NHS Foundation Trust

Publications: 34

Rafael Rosell

Rafael Rosell

Autonomous University of Barcelona

Publications: 33

Nick Thatcher

Nick Thatcher

University of Manchester

Publications: 33

Luis Paz-Ares

Luis Paz-Ares

Complutense University of Madrid

Publications: 31

Giuseppe Pelosi

Giuseppe Pelosi

University of Milan

Publications: 31

Egbert F. Smit

Egbert F. Smit

VU University Medical Center

Publications: 30

Frances A. Shepherd

Frances A. Shepherd

Princess Margaret Cancer Centre

Publications: 29

Natasha B. Leighl

Natasha B. Leighl

Princess Margaret Cancer Centre

Publications: 29

Trending Scientists

Esther Collantes-Fernández

Esther Collantes-Fernández

Complutense University of Madrid

Yonghui Li

Yonghui Li

University of Sydney

Elizabeth Kuipers

Elizabeth Kuipers

King's College London

Silvana Gaetani

Silvana Gaetani

Sapienza University of Rome

Lauren M. Aleksunes

Lauren M. Aleksunes

Rutgers, The State University of New Jersey

Elmar Schiebel

Elmar Schiebel

Heidelberg University

Wei-Cai Yang

Wei-Cai Yang

Chinese Academy of Sciences

Isabelle P. Oswald

Isabelle P. Oswald

Federal University of Toulouse Midi-Pyrénées

J. Douglas Walker

J. Douglas Walker

University of Kansas

Ronald J. Steel

Ronald J. Steel

The University of Texas at Austin

Amala Mahadevan

Amala Mahadevan

Woods Hole Oceanographic Institution

Frank Moulaert

Frank Moulaert

KU Leuven

William G. Hoover

William G. Hoover

University of California, Davis

John K. Carlson

John K. Carlson

National Oceanic and Atmospheric Administration

Ilse Storch

Ilse Storch

University of Freiburg

Debra P. C. Peters

Debra P. C. Peters

United States Department of Agriculture

Related Medicine Rankings & Guides

2026 Fastest Online Surgical Tech Certificate Programs

2026 Fastest Online Surgical Tech Certificate Programs
2026 Easiest Direct-Entry MSN Programs to Get Into

2026 Easiest Direct-Entry MSN Programs to Get Into
2026 Fastest Doctor of Nursing Practice (DNP) Degree Programs

2026 Fastest Doctor of Nursing Practice (DNP) Degree Programs
2026 Best Occupational Therapy Programs

2026 Best Occupational Therapy Programs
2026 Easiest RN-to-BSN Online Programs

2026 Easiest RN-to-BSN Online Programs
2026 Most Affordable Online MSN in Nurse Executive Leadership Programs

2026 Most Affordable Online MSN in Nurse Executive Leadership Programs
August 2026 Best Online Physician Assistant Master’s Programs

August 2026 Best Online Physician Assistant Master’s Programs
2026 Most Affordable Online AGNP Programs

2026 Most Affordable Online AGNP Programs
2026 Best Nursing Schools in Texas – Accredited ADN, BSN, MSN Programs

2026 Best Nursing Schools in Texas – Accredited ADN, BSN, MSN Programs
2026 CMAA vs. CCMA Certification: Explaining the Difference

2026 CMAA vs. CCMA Certification: Explaining the Difference
2026 Most Affordable Online Health Information Management Degree Programs

2026 Most Affordable Online Health Information Management Degree Programs
2026 Easiest Medical Degree Programs

2026 Easiest Medical Degree Programs
2026 Best Shortest Online PMHNP Certificate Programs

2026 Best Shortest Online PMHNP Certificate Programs
2026 Healthcare Administration Degree Guide: Costs, Requirements & Job Opportunities

2026 Healthcare Administration Degree Guide: Costs, Requirements & Job Opportunities
2026 Best Online Dual FNP/PMHNP Degree Programs

2026 Best Online Dual FNP/PMHNP Degree Programs
2026 Best Pharmacy Schools & Pharmacist Programs Requirements in Florida: Online & Campus

2026 Best Pharmacy Schools & Pharmacist Programs Requirements in Florida: Online & Campus
August 2026 Fast Track LPN Programs Online - 6, 9, 10, 11, 12 Month Programs

August 2026 Fast Track LPN Programs Online - 6, 9, 10, 11, 12 Month Programs
2026 Best Nursing Schools in Ohio – Accredited ADN, BSN & MSN Programs

2026 Best Nursing Schools in Ohio – Accredited ADN, BSN & MSN Programs
2026 Most Affordable Online DNP Programs

2026 Most Affordable Online DNP Programs
2026 Best Nurse Practitioner Programs in Oklahoma – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in Oklahoma – Accredited Schools Online & Campus
2026 Best Online FNP Programs That Provide Preceptors

2026 Best Online FNP Programs That Provide Preceptors

Recently Published Articles

2026 Most Affordable Online Electrician Trade School Programs

2026 Most Affordable Online Electrician Trade School Programs
2026 How Many Credits Do You Need for a Criminal Justice Bachelor's Degree?

2026 How Many Credits Do You Need for a Criminal Justice Bachelor's Degree?
2026 Different Types of Medical Billing & Coding Degrees and Their Salaries

2026 Different Types of Medical Billing & Coding Degrees and Their Salaries
2026 Best Anthropology Degrees for Working Adults

2026 Best Anthropology Degrees for Working Adults
2026 Best Accredited Online Engineering Management Bachelor's Degree Programs

2026 Best Accredited Online Engineering Management Bachelor's Degree Programs
2026 Associate to Bachelor's in Cybersecurity: Transfer Pathways Explained

2026 Associate to Bachelor's in Cybersecurity: Transfer Pathways Explained
2026 Military-Friendly Online Architecture Master's Degree Programs: Benefits, Accreditation & Career Outcomes

2026 Military-Friendly Online Architecture Master's Degree Programs: Benefits, Accreditation & Career Outcomes
2026 Certified Nurse Aide (CNA) License Education Requirements in North Carolina

2026 Certified Nurse Aide (CNA) License Education Requirements in North Carolina
2026 Logistics Degree vs. Certificate: Which Should You Choose?

2026 Logistics Degree vs. Certificate: Which Should You Choose?
2026 Online Accounting Bachelor's Degree Programs With No Application Fee

2026 Online Accounting Bachelor's Degree Programs With No Application Fee
2026 Best Online Adult-Gerontology ACNP Graduate Certificate Programs

2026 Best Online Adult-Gerontology ACNP Graduate Certificate Programs
2026 Easiest Online Health Studies Degree Programs That Pay Well: High-Salary Degrees with Simple Admissions

2026 Easiest Online Health Studies Degree Programs That Pay Well: High-Salary Degrees with Simple Admissions
2026 Fastest Online Aerospace Engineering Degree Programs You Can Finish in Under 2 Years

2026 Fastest Online Aerospace Engineering Degree Programs You Can Finish in Under 2 Years
2026 Fastest Online Urban Planning Degree Programs You Can Finish in Under 2 Years

2026 Fastest Online Urban Planning Degree Programs You Can Finish in Under 2 Years
2026 Most Affordable Online Pharmacy Technician Certificate Programs

2026 Most Affordable Online Pharmacy Technician Certificate Programs
2026 Best Online Nursing Degree Programs

2026 Best Online Nursing Degree Programs
2026 Fastest Online Supply Chain Management Degree Programs You Can Finish in Under 2 Years

2026 Fastest Online Supply Chain Management Degree Programs You Can Finish in Under 2 Years
2026 Is a Library Science Master's Degree Worth It? ROI, Salary & Career Impact

2026 Is a Library Science Master's Degree Worth It? ROI, Salary & Career Impact
2026 Associate to Bachelor's in Game Programming & Development: Transfer Pathways Explained

2026 Associate to Bachelor's in Game Programming & Development: Transfer Pathways Explained
2026 Best Online Industrial Engineering Degree Master's Programs for Career Changers

2026 Best Online Industrial Engineering Degree Master's Programs for Career Changers
2026 Fastest Online Cybersecurity Bachelor's Degree Programs You Can Finish in 3 Years or Less

2026 Fastest Online Cybersecurity Bachelor's Degree Programs You Can Finish in 3 Years or Less